Alaunos Therapeutics Regains Compliance With Nasdaq Stockholders' Equity Requirement

Bitget2026/10/23 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nasdaq confirmed on October 22, 2026, that Alaunos Therapeutics regained compliance with its $2.5 million minimum stockholders' equity requirement.
The delisting matter is closed. The common stock will continue trading on The Nasdaq Capital Market.
Compliance followed completion of a private placement financing on October 14, 2026.
The Nasdaq Hearings Panel hearing scheduled for November 10, 2026, was canceled.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alaunos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-430507), on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alaunos Therapeutics Regains Compliance With Nasdaq Stockholders' Equity Requirement

You may also like

Crypto prices